Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arkansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arkansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arkansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Omer Khalil (NPI 1467671792)

Field	Value
Entity Type	Individual
Organization	Omer Khalil
Address	8901 Carti Way
City	Little Rock
State	AR
ZIP	72205
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	April 25, 2007

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

Provider profile and scale: OMER KHALIL is a Hematology & Oncology Physician based in LITTLE ROCK, AR with an NPI enumerated on 2007-04-25 (~19 years ago). Lifetime Medicare revenue recorded is $2.4M and there is no Medicaid billing on file, indicating the provider’s activity in these datasets is effectively single-payer Medicare in scope.

Revenue concentration is high: the precomputed top-3 Medicare codes account for 64.1% of this provider’s total Medicare revenue, and a single code, J9271, alone represents 47.5% of Medicare revenue ($1.1M). That concentration signals material financial dependence on a small set of injectable therapies.

Service-line footprint: the code mix is consistent with an outpatient oncology infusion practice — high-revenue biologic/immunotherapy J9271 (pembrolizumab) is dominant, supplemented by chemotherapy agents and supportive injections (J9264, J9041, J0897) and chemotherapy administration codes (96413, 96365, G0498, 96417). Frequent E/M codes (99214/99213) and routine labs (85025, 80053, 82728) further indicate integrated office-based management and monitoring of oncology patients.

Competitive standing on the top drug: J9271 ranks #182 of 1841 nationally (90th percentile) and is characterized in the dataset as a 'typical, unremarkable volume' position; while this code drives nearly half of the provider’s Medicare dollars, nationally the provider is not among the very top billers for this drug but does operate at solid volume.

Notable national leadership in select injectables: J1437 (ferric derisomaltose) ranks #18 of 581 providers (97th percentile) and is described as 'notably above typical national volume', while J0885 (epoetin alfa) ranks #38 of 953 (96th percentile) also 'notably above typical national volume'. These ranks show the provider is a high-volume national biller for certain supportive care or anemia-related infusions.

E/M and procedural volume are statistical outliers: the provider’s use of office E/M codes 99214 and 99213 are in the extreme outlier range (99214: 98th percentile; 99213: 99th percentile), which suggests unusually high longitudinal office-based patient management relative to national peers and a sizable ambulatory workload in addition to infusion services.

Lab and ancillary services support infusions and monitoring: high claim volumes for 85025 (CBC, 5.8K claims; ranks in the 99th percentile), 36415 (venipuncture, 5.5K claims; 100th percentile), and 80053 (CMP, 3.2K claims; 98th percentile) indicate routine in-house laboratory testing tied to treatment and monitoring workflows common in infusion oncology settings.

Payer-mix and operational risk: with $2.4M in Medicare revenue and 'none below — this provider has no Medicaid billing on file,' the provider’s reported business is concentrated in Medicare. That lack of Medicaid exposure reduces diversification of payer risk and implies that changes in Medicare reimbursement, drug pricing, or utilization of high-revenue drugs like J9271 could have outsized impact on the practice’s revenue base.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

88 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	26,800	$40	$1.1M
J1437	Injection, ferric derisomaltose, 10 mg	11,700	$20	$198.9K
J0897	Injection, denosumab, 1 mg	10,440	$20	$177.5K
J9264	Injection, paclitaxel protein-bound particles, 1 mg	10,800	$10	$108K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	2,800	$40	$100.8K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	16,410	$10	$98.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,150	$90	$98K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,120	$60	$62.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	620	$90	$53.2K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	410	$120	$50.3K

Showing 1–10 of 88

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 88 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arkansas Distribution

Omer Khalil — 10 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arkansas

Full comparison — all codes billed, vs. state median

88 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	9	40	20,700	$40	$896.3K
J1569	6	10	2,560	$40	$120.3K
J1437	2	20	6,450	$20	$107.8K
J9264	4	10	9,300	$10	$96.2K
J0897	23	160	2,580	$20	$89.7K
J0885	3	40	4,070	$10	$38K
96413	22	80	380	$90	$36.6K
99214	123	4,300	130	$70	$18.8K
88185	10	20	780	$20	$18.5K
99233	784	960	130	$90	$18.2K

Showing 1–10 of 88

Related Providers

Other providers that share a Tax Identification Number (TIN) with Omer Khalil, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Central Arkansas Radiation Therapy Institute Inc	AR	Hematology & Oncology Physician	$0	$11M
Central Arkansas Radiation Therapy Institute Inc	AR	Radiation Oncology Physician	$6.7M	$3.6M
Kamal Patel	AR	Hematology & Oncology Physician	$5.7M	$0
Ryan Hall	AR	Hematology & Oncology Physician	$4.6M	$0
Balagopalan Nair	AR	Hematology & Oncology Physician	$4.1M	$0
Lawrence Mendelsohn	AR	Hematology & Oncology Physician	$3.4M	$0
Jamie Burton	AR	Hematology & Oncology Physician	$2.8M	$0
Kewen Jauss	AR	Hematology & Oncology Physician	$2.8M	$0
Mariann Harrington	AR	Hematology & Oncology Physician	$2.7M	$0
Appalanaidu Sasapu	AR	Hematology & Oncology Physician	$2.6M	$0

Nearby Providers

Other providers in the same ZIP code as Omer Khalil, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Arkansas For Medical Sciences	AR	General Acute Care Hospital	$0	$87.2M
University Of Arkansas For Medical Sciences	AR	Internal Medicine Physician	$0	$28.6M
University Of Arkansas For Medical Sciences	AR	Pediatrics Physician	$0	$27.6M
Arkansas Department Of Health Immunizations	AR	Public Health or Welfare Agency	$0	$19.3M
Baptist Health	AR	General Acute Care Hospital	$0	$16.4M
Arkansas Department Of Health Family Planning Clinic	AR	Public Health or Welfare Agency	$0	$15.6M
Pediatrix Medical Group Of Arkansas PA	AR	Neonatal-Perinatal Medicine Physician	$0	$14.6M
Chenal Family Therapy, Plc	AR	Mental Health Counselor	$0	$12.2M
Francis A. Allen School For Exceptional Children, Inc.	AR	Developmentally Disabled Services Day Training Agency	$0	$11.9M
Arkansas Department Of Health Std	AR	Public Health or Welfare Agency	$0	$8.4M

Omer Khalil — Billing Profile & Reimbursement Data

Sign up for Omer Khalil — Billing Profile & Reimbursement Data policy alerts

Omer Khalil — Billing Profile & Reimbursement Data

Sign up for Omer Khalil — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References